...
首页> 外文期刊>International Journal of Pharmaceutical and Healthcare Marketing >Ethical issues in the pharmaceutical industry: an analysis of US newspapers
【24h】

Ethical issues in the pharmaceutical industry: an analysis of US newspapers

机译:制药行业中的道德问题:对美国报纸的分析

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose – The purpose of this study is to analyze newspaper coverage of ethical issues in the pharmaceutical industry. Design/methodology/approach – The top five US newspapers were audited over two years and yielded 376 articles, which appeared as front-page stories or editorials. First, headlines were analyzed and categorized as positive, negative, or neutral toward the industry. Next, the full-text of each article was analyzed and ethical issues in each article were categorized. Then, articles were evaluated to determine whether the opposing point of view was included. Finally, comparisons were made between the identified issues and the issues cited by PhRMA, the pharmaceutical industry's trade association. Findings – Analysis of the ethical issues revealed different results for the two years. In 2004, the most common issues covered were drug pricing, data disclosure and importation/reimportation. In 2005, drug safety was the number one issue, due to Vioxx® with drug pricing a distant second. Headlines were negative 57.1 percent in 2004 and 43.9 percent in 2005. Full-text articles were negative 69.5 percent in 2004 and 60.1 percent in 2005. The opposing point of view was included 77.7 percent in 2004 and increased to 82.7 percent in 2005. Ethical issues cited by PhRMA, (e.g. drug pricing), received heavy coverage but several identified issues were not on PhRMA's list, notably drug safety. Practical implications – Pharmaceutical companies need to take action to address the negative impression about them. Originality/value – This research establishes a practical methodology to evaluate newspaper coverage of ethical issues involving the pharmaceutical industry.
机译:目的–这项研究的目的是分析报纸对制药行业道德问题的报道。设计/方法/方法-过去两年中,对美国排名前五位的报纸进行了审核,并发表了376条文章,这些文章以头版故事或社论的形式出现。首先,对行业头条进行分析并将其分类为正面,负面或中立。接下来,对每篇文章的全文进行了分析,并对每篇文章中的道德问题进行了归类。然后,对物品进行评估,以确定是否包括相反的观点。最后,在已识别的问题与制药行业贸易协会PhRMA引用的问题之间进行了比较。调查结果–对道德问题的分析揭示了两年的不同结果。 2004年,涉及的最常见问题是药品定价,数据披露和进口/再进口。 2005年,由于Vioxx®药品价格排名第二,药品安全性成为第一要务。头条新闻在2004年下降了57.1%,在2005年下降了43.9%。全文在2004年下降了69.5%,在2005年下降了60.1%。相反的观点包括2004年的77.7%和2005年的82.7%。道德问题PhRMA引用的文献(例如药品定价)得到了广泛的报道,但PhRMA并未列出几个已确定的问题,尤其是药物安全性。实际意义–制药公司需要采取行动来消除对其的负面印象。原创性/价值–这项研究建立了一种实用的方法来评估报纸对涉及制药业的道德问题的报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号